The problems created by Senator McCain continue to be ever present.  Our friend, Senator Durbin has asked that we provide his office with additional background about the military nature of the research performed by the Congressionally Directed Medical Research Programs (CDMRP), including the Prostate Cancer Research Program (PCRP).

In addition there is a very misguided support group leader from a southern California city who has responded to Malecare in a very negative manner to my request for your  support in encouraging  the continued funding of the PCRP CDMRP.  This support group leader, despite his great work and efforts in helping men diagnosed with prostate cancer clearly has no idea of the importance of this program.

In response to Senator Durbon’s request and to hopefully inform the misguided support group leader as well as contribute to the general knowledge base I will share my notes about the current contributions of this vital program.

In reference to the request for specific stories in support of the military relevance I do want to make sure that it is known for the prostate cancer CDMRP that the program is directly responsible for the basic science as well as the initial clinical trials for three of the six treatments that are used to treat men with advanced, castrate resistant metastatic prostate cancer.

FYI – The drugs that I am referring to are:

abiraterone  (Zytiga)

enzalutamide (Xtandi)

Radium 223 (Xofigo)

It is well known that men who have been exposed to agent orange (both “boots on the ground as